Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Systemic proinflammatory−profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome

Fig. 1

Myocardial fibrosis and left ventricular diastolic function in aortic stenosis patients according to diabetes and diabetes medication status. a, b Comparison of the degree of diastolic dysfunction in a patients with versus without diabetes and in b patients stratified by the diabetes medication status. c, d Comparison of late gadolinium enhancement (LGE) in c patients with versus without diabetes and in d patients stratified by the diabetes medication status. e, f Comparison of extracellular volume fraction (ECV) in e patients with versus without diabetes and in f patients stratified by the diabetes medication status. g, h Representative LGE and ECV images of cardiac magnetic resonance taken from g a non-diabetic aortic stenosis patient (no LGE; ECV 26.4%) versus h a diabetic aortic stenosis patient on oral hypoglycemic agent (midwall LGE in the septal and lateral wall; ECV 34.5%). DM, diabetes mellitus; ECV, extracellular volume; LGE, late gadolinium enhancement; LVDD, left ventricular diastolic dysfunction; OHA, oral hypoglycemic agents

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840